Table 1.
Pooled estimate (mean/frequency) | 95%CI | Npatients | Nsites | I2 | |
---|---|---|---|---|---|
| |||||
Demographics | |||||
Sex (% women) | 60% | [56, 64] | 1092 | 36 | 35.0 |
Handedness (% right) | 93% | [90, 95] | 872 | 32 | 42.8 |
Years of education | 14.1 | [13.9, 14.2] | 949 | 35 | 93.1 |
APOE (% e4 carriers) | 43% | [35, 50] | 451 | 22 | 55.5 |
Clinical | |||||
Age at symptom onset, years | 59.4 | [58.9, 59.8] | 1031 | 34 | 77.4 |
Age at diagnosis, years | 63.2 | [62.8, 63.6] | 1067 | 36 | 76.8 |
Age at death, years | 70.5 | [69.5, 71.4] | 227 | 20 | 72.7 |
Diagnosis (% PCA pure) | 80% | [72, 89] | 968 | 34 | 97.9 |
MMSE at diagnosis, points (range : 0–30) | 20.7 | [20.4, 21.1] | 904 | 31 | 69.9 |
CDR at diagnosis (% CDR≥1) | 62% | [53, 71] | 558 | 27 | 81.1 |
Mendez criteria (% fulfilled) | 75% | [60, 90] | 535 | 21 | 99.4 |
Tang-Wai criteria (% fulfilled) | 80% | [68, 92] | 535 | 21 | 98.6 |
Early disturbance of posterior function (% yes) | 91% | [85, 97] | 992 | 36 | 98.1 |
Insidious onset and gradual progression (% yes) | 99% | [98, 99] | 809 | 34 | 0 |
Mean values or frequency, and their corresponding 95% confidence intervals are derived from the meta-analysis of all available data. Sites with only one available datapoint (two sites for “MMSE”, one site for “age at death”) were not included in the meta-analysis. Raw data, including breakdown of each site, is presented in Supplementary Figures 1–10. Abbreviations: MMSE: Mini-Mental State Examination, CDR: Clinical Dementia Rating scale.